Clinical Trials Browser

Has results × bemarituzumab × Gastrointestinal × Clear all

NCT02318329 2024-06-04

Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors

Phase 1 Completed

79 enrolled 21 charts

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT03343301 2024-02-28

FIGHT

Phase 1 Completed

12 enrolled 17 charts

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT03694522 2024-02-28

FIGHT

Phase 2 Completed

155 enrolled 19 charts

Gastrointestinal

Stomach Neoplasms